The AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive NGS Genetic DNA Test is a crucial diagnostic tool for identifying genetic predispositions to neurological disorders. Priced at 40,000 KSh, this test provides insights into the genetic factors associated with spastic ataxia, helping patients and families make informed health decisions.
- Call Anytime: +254 704 150555
- info@biopassiondiagnostics.co.ke
AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test
Genetic Testing
AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test
KSh 56,000.00
Regular price
KSh 47,600.00
Current price
-15%
What Is the AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test?
The AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive NGS Genetic DNA Test is an advanced diagnostic tool that utilizes next-generation sequencing (NGS) technology to identify mutations in the AFG3L2 gene. This test is particularly important for individuals who may be at risk for spastic ataxia, a neurological disorder characterized by progressive loss of coordination and balance.
Who Should Consider This Test?
Individuals who experience symptoms such as:
- Progressive loss of coordination
- Difficulty walking or maintaining balance
- Family history of neurological disorders
are encouraged to consider this test. Additionally, individuals with a clinical history suggestive of spastic ataxia should consult their healthcare provider about the potential benefits of genetic testing.
What Does the Test Detect or Measure?
This genetic test measures the presence of specific mutations in the AFG3L2 gene that are associated with autosomal recessive spastic ataxia type 5. By analyzing the DNA from a blood sample, the test can detect genetic variations that may contribute to the development of this disorder.
What the Results May Show
Results from the AFG3L2 Gene Spastic Ataxia Type 5 test will indicate whether any mutations were detected. A positive result may suggest a higher risk for developing spastic ataxia, while a negative result can provide reassurance. It is important to discuss your results with a qualified healthcare professional who can guide you through the implications and next steps.
Benefits or Clinical Value
- Provides clarity on genetic predispositions to neurological disorders.
- Facilitates informed decision-making regarding treatment and management options.
- Helps in family planning by identifying carriers of the AFG3L2 gene mutation.
- Enables access to appropriate genetic counseling and support services.
Pricing
| Test Name | Current Price | Regular Price |
|---|---|---|
| AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test | KSh 47,600.00 | KSh 56,000.00 |
Book the AFG3L2 Gene Spastic Ataxia Type 5 Autosomal Recessive Genetic Test
Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.
SKU: 97108695bd93 | Category: Genetic Testing